Patient Registries

Registry-based evidence has become an industry standard due to the consistent way in which the data is collected. Whether you need a disease or a product registry, we can support you.

Patient registries solutions

Designing and executing registries with our team

Regulatory authorities increasingly value real-world data and registries in their decision-making processes. Registries can be leveraged throughout the product development process to describe the natural history of a disease, determine the clinical effectiveness or cost-effectiveness of healthcare products and services, measure or monitor safety and harm, and assess the current quality of care. The value derived from a registry is broad and deep, as the data can serve multiple purposes for stakeholders across the industry.

Disease and product registry development

We can help develop custom disease and product registries to suit your specific real-world data needs.

Development of disease registries

Disease registries include patients suffering from or at risk of a disease, and are an effective way to investigate the natural history of the condition. These registries can inform clinical trial planning by identifying patients for enrollment and generating supplementary evidence as an external control arm.

Development of product registries

Our team can also support you in the development of product registries, which provide information about patients treated with a specific product or device.

These registries can be used to fulfill post-marketing authorization requirements for assessing safety, real-world effectiveness, or harm.

A flexible approach to registry development

The Oracle team of researchers, methodologists, and statisticians brings extensive experience across many therapeutic areas. Our experts identify existing real-world data (RWD) that can be used to create registries. We seek to partner with, and have exclusive access to, databases around the world, leveraging existing RWD to build new registries.

A hybrid approach that combines primary prospective data with existing RWD can also provide more comprehensive answers when needed.

Where the relevant data doesn’t exist, we can assist in the design and creation of new registries via primary data collection with direct-to-patient or site-based methodologies. We have extensive experience identifying existing patient-centered outcomes measures and developing new measures including patient-reported outcomes (PROs).

A longstanding track record

With more than 40 years of experience and over 1 million patients enrolled in Oracle Life Sciences registries, we’re experts in designing and executing regulatory-grade registries. We’re proud to be a partner of choice for patient advocacy groups such as the International Gaucher Alliance (IGA) and the Cure and Action for Tay-Sachs (CATS) Foundation.

Whether you’re focused on a specific disease and its natural history, or you’re trying to meet your regulatory requirements, we can help identify the best methodology and data to meet your needs.

从 Oracle 生命科学开始


订阅博客

了解最新观点和优秀实践,助力临床成功。


获取技术支持

了解技术支持团队联系方式和资源。


关注我们的播客

了解思想领袖关于生命科学行业趋势的真知灼见。


联系我们

联系我们,了解关于临床研究和药物警戒的更多信息。

注:为免疑义,本网页所用以下术语专指以下含义:

  1. Oracle专指Oracle境外公司而非甲骨文中国。
  2. 相关Cloud或云术语均指代Oracle境外公司提供的云技术或其解决方案。